IÑAKI
ZORRILLA MARTÍNEZ
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublications en collaboration avec des chercheurs de Universidad del País Vasco/Euskal Herriko Unibertsitatea (39)
2024
-
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Molecular Psychiatry
-
Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter
Journal of Affective Disorders, Vol. 351, pp. 649-660
-
Clinical predictors and psychosocial risk factors of suicide attempt severity
Spanish Journal of Psychiatry and Mental Health
-
Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study
Nutrients, Vol. 16, Núm. 2
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
2023
-
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
BMC psychiatry, Vol. 23, Núm. 1, pp. 178
-
Experiences and impact on the quality of life of people with long COVID
Gaceta Sanitaria, Vol. 37
-
Incidence of mental disorders in the general population aged 1–30 years disaggregated by gender and socioeconomic status
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 6, pp. 961-971
-
Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management
International Journal of Bipolar Disorders, Vol. 11, Núm. 1
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition
World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317
-
Modelling the risk of hospital admission of lab confirmed SARS-CoV-2-infected patients in primary care: a population-based study
Internal and emergency medicine, Vol. 17, Núm. 4, pp. 1211-1221
-
Perceptions and experiences of 7-8 year old schoolchildren in the Basque Country during the COVID-19 health alert
Gaceta Sanitaria, Vol. 36, Núm. 1, pp. 19-24
-
Relevance of well-being, resilience, and health-related quality of life to mental health profiles of European adolescents: results from a cross-sectional analysis of the school-based multinational UPRIGHT project
Social Psychiatry and Psychiatric Epidemiology, Vol. 57, Núm. 2, pp. 279-291
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1